AVARA PHARMACEUTICALS INC.

Lobbying client · Oklahoma · filed 2025 to 2026

Generic Pharmaceutical Manufacturing Company

$60,000 Reported spend

3 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (69969), not by name.

Firms hired 1

THE VOGEL GROUP $60,000 3 filings

Reported by year 2 years

2026 $0 1 filing
2025 $60,000 2 filings

Issues lobbied 1

Health Issues 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 3 total

1T

THE VOGEL GROUP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · posted Apr 20, 2026

View → Q4

THE VOGEL GROUP

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 20, 2026

View → RR

THE VOGEL GROUP

4th Quarter (Oct 1 - Dec 31) 2025 · posted Nov 26, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.